Nabel Gary J.
- SEC CIK
- 0001867450
No open-market purchases or sales filed in the past year.
Current role at each company
- CADL Candel Therapeutics, Inc.Directoras of Jun 24, 2026
- SIGA Siga Technologies IncDirectoras of Jun 10, 2026
- OPK Opko Health, Inc.Chief Innovation Officeras of May 29, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nabel Gary J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OPK Opko Health, Inc.
Chief Innovation Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 (view filing) | Jan 8 | 2 days | Nabel Gary J.Chief Innovation Officer | PPurchase | +216.2K | $0.93 | +$201.0K | New position107.5K after | 3 lots |
| May 8, 2023 (view filing) | May 5 | 3 days | Nabel Gary J.Chief Innovation Officer | PPurchase | +187.6K | $1.81 | +$340.1K | +248.6%263.1K after | 7 lots |
| May 8, 2023 (view filing) | May 5 | 3 days | Nabel Gary J.Chief Innovation Officer | PPurchase | +272.6K | $1.84 | +$501.0K | New position242.7K after | 7 lots |
| Jun 24, 2022 (view filing) | Jun 22 | 2 days | Nabel Gary J.Chief Innovation Officer | PPurchase | +240.0K | $2.49 | +$597.6K | New position80.0K after | 7 lots |
| May 19, 2022 (view filing) | May 12-18 | 7 daysLate | Nabel Gary J.Chief Innovation Officer | PPurchase | +75.5K | $2.88 | +$217.1K | New position75.5K after | 2 lots |